BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 29244990)

  • 1. Clinical and Epidemiological Profile of Breast Cancer in Mexico: Results of the Seguro Popular.
    Reynoso-Noverón N; Villarreal-Garza C; Soto-Perez-de-Celis E; Arce-Salinas C; Matus-Santos J; Ramírez-Ugalde MT; Alvarado-Miranda A; Cabrera-Galeana P; Meneses-García A; Lara-Medina F; Bargalló-Rocha E; Mohar A
    J Glob Oncol; 2017 Dec; 3(6):757-764. PubMed ID: 29244990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cervical Cancer Treatment Gap in Mexico Under
    McClellan SP; Unger-Saldaña K; Espinosa-Tamez P; Suazo-Zepeda E; Potter MB; Barquet-Muñoz SA; Torres-Ibarra L; Lamadrid-Figueroa H; Lajous M
    Health Syst Reform; 2023 Dec; 9(1):2272371. PubMed ID: 37944505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption.
    Knaul FM; Arreola-Ornelas H; Touchton M; McDonald T; Blofield M; Avila Burgos L; Gómez-Dantés O; Kuri P; Martinez-Valle A; Méndez-Carniado O; Nargund RS; Porteny T; Sosa-Rubí SG; Serván-Mori E; Symes M; Vargas Enciso V; Frenk J
    Lancet; 2023 Aug; 402(10403):731-746. PubMed ID: 37562419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the dynamics of the Seguro Popular de Salud policy implementation in Mexico from a complex adaptive systems perspective.
    Nigenda G; González-Robledo LM; Juárez-Ramírez C; Adam T
    Implement Sci; 2016 May; 11():68. PubMed ID: 27177618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Seguro Popular on the Progression of Disabilities Among Older Adults With Chronic Degenerative Diseases in Mexico.
    van Gameren E; Enciso N
    Res Aging; 2023; 45(9-10):599-608. PubMed ID: 36515312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and prognosis of young breast cancer patients treated in a public comprehensive cancer centre in Brazil: A retrospective cohort study.
    Carreiro KB; Goncalves R; Mota BS; Soares JM; Baracat EC; Filassi JR
    Cancer Epidemiol; 2023 Oct; 86():102437. PubMed ID: 37562089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Torres-Sánchez LE; Hernández-Pérez JG; Escamilla-Nuñez C; Rodríguez-Covarrubias F; Manzanilla-García H; Mohar A; Morales-Carmona E; Espin-Arellano LI; Hernández-Ávila JE; Lajous M
    Salud Publica Mex; 2023 Apr; 65(3, may-jun):236-244. PubMed ID: 38060881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcomes of older women with breast cancer in Mexico.
    Cabrera-Galeana P; Soto-Perez-de-Celis E; Reynoso-Noverón N; Villarreal-Garza C; Arce-Salinas C; Matus-Santos J; Ramírez-Ugalde MT; Alvarado-Miranda A; Meneses-García A; Lara-Medina F; Torres-Dominguez J; Bargalló-Rocha E; Mohar A
    J Geriatr Oncol; 2018 Nov; 9(6):620-625. PubMed ID: 29691196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer: Metastasis, Molecular Subtypes, and Overweight and Obesity in Veracruz, Mexico.
    Alarcón Rojas CA; Alvarez-Bañuelos MT; Morales-Romero J; Suárez-Díaz H; Hernández-Fonseca JC; Contreras-Alarcón G
    Clin Breast Cancer; 2019 Feb; 19(1):e166-e171. PubMed ID: 30236925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world data on triple-negative breast cancer in Latin America and the Caribbean.
    Tiscoski KA; Giacomazzi J; Rocha MS; Gössling G; Werutsky G
    Ecancermedicalscience; 2023; 17():1635. PubMed ID: 38414969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Outcomes of Patients With Breast Cancer in a Mexican Population.
    Grajales-Alvarez R; Gutiérrez-Mata A; Pichardo-Piña C; Gutiérrez-De la Barrera M; Dip-Borunda K
    JCO Glob Oncol; 2024 Feb; 10():e2300233. PubMed ID: 38330273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer survival after mammography dissemination in Brazil: a population-based analysis of 2,715 cases.
    Fernandes JO; Machado BF; Cardoso-Filho C; Nativio J; Cabello C; Vale DB
    BMC Womens Health; 2023 Dec; 23(1):644. PubMed ID: 38049765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer: Clinical-Epidemiological Profile and Toxicities of Women Receiving Treatment with Taxanes in the Amazon Region.
    Costa MSCR; Fernandes MR; Pereira EEB; Leal DFDVB; Coelho RCC; Menezes EDS; Modesto AAC; Assumpção PP; Burbano RMR; Santos SEBD; Santos NPCD
    J Pers Med; 2023 Sep; 13(10):. PubMed ID: 37888069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer survival in Mexico between 2007 and 2016 in women without social security: a retrospective cohort study.
    Unger-Saldaña K; Bandala-Jacques A; Huerta-Gutierrez R; Zamora-Muñoz S; Hernández-Ávila JE; Cabrera-Galeana P; Mohar A; Lajous M
    Lancet Reg Health Am; 2023 Jul; 23():100541. PubMed ID: 37408951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of the addition of CDK4/6 inhibitors to standard endocrine therapy in first-line treatment of women with advanced HR+/HER2- breast cancer in Mexico.
    Molina-Jaimes M; Galindo-González A; Verduzco-Aguirre HC; Bautista-Arredondo S; Reyes-Terán G; Soto-Perez-de-Celis E
    Clin Transl Oncol; 2024 Jan; 26(1):239-244. PubMed ID: 37329428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of triple negative breast cancer gene expression profiles in Mexican patients.
    Ortiz Valdez E; Rangel-Escareño C; Matus Santos JA; Vázquez Romo R; Guijosa A; Villarreal-Garza C; Arrieta O; Rodríguez-Bautista R; Caro-Sánchez CH; Ortega Gómez A
    Mol Clin Oncol; 2023 Jan; 18(1):5. PubMed ID: 36605097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Associating prognostic factors with clinical results in locally advanced breast cancer].
    Ramírez-Torres N; Reyes-López A; Hernández-Valencia M
    Rev Med Inst Mex Seguro Soc; 2023 Jan; 61(1):88-98. PubMed ID: 36542781
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Magallanes-Garza GI; Santuario-Facio SK; Lira-Albarrán S; Varela-Varela AF; Cardona-Huerta S; Ruiz-Flores P; Haro-Santa-Cruz J; Perez-Paramo YX; Gomez-Macias GS; Davila-Gonzalez D; Valero-Gomez J; Borrego-Soto G; Rojas-Martinez A; Ortiz-Lopez R
    J Oncol; 2022; 2022():6001947. PubMed ID: 36478748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of germline
    Villarreal-Garza C; Ferrigno AS; Aranda-Gutierrez A; Frankel PH; Ruel NH; Fonseca A; Narod S; Chavarri-Guerra Y; Sifuentes E; Magallanes-Hoyos MC; Herzog J; Castillo D; Alvarez-Gomez RM; Mohar-Betancourt A; Weitzel JN
    Cancer Res Commun; 2021 Dec; 1(3):140-147. PubMed ID: 35875314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.